ChartRow logo
Data provided bySource: Twelve Data
Share this page

COO — The Cooper Companies Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in COO be worth today? →
COO returns: By year · By month · By week · Trailing

Price data

Price
$62.36
YTD price return
-23.91%
YTD total return
-23.91%
Next earnings
Dec 3, 2026
Market cap
11.9B
Enterprise value
14.5B
Shares outstanding
190.2M
52W low
$51.01
52W high
$89.83
From 52W high
-30.58%
From 52W low
+22.25%
52W range
29%$51.01–$89.83
Beta
0.82

Volume

Rel volume
0.60×
30D volume
3.4M
30D $ vol
199.6M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
+$1.9M
Insider net 1Y
+$1.9M

Form 4 transactions by trade date, as filed; latest on file 2026-09-16.

Fundamentals

Sales (ttm)
4.2B
Sales/share
$22.28
EPS (ttm)
$2.91
FCF (ttm)
678M
FCF/share
$3.57
Book value/share
$43.80
Net margin
13.46%
ROE
6.85%
ROA
4.50%
Debt / equity
0.23×
Current ratio
1.22

Growth (CAGR, ttm) · 10Y

Sales
+4.73%+6.43%+8.29%+8.33%
Net income
+39.88%+27.47%-27.85%+8.59%
FCF
+64.66%+45.16%+5.21%+10.71%
Shares
-4.36%-1.35%-0.73%-0.25%

Per-share growth (CAGR, ttm) · 10Y

EPS
+43.33%+28.17%-27.63%+8.59%
Sales/share
+9.50%+7.89%+9.09%+8.60%
FCF/share
+72.16%+47.15%+5.98%+10.99%
Book value/share
+4.25%+4.84%+4.95%+12.08%
Dividend/share
-50.19%-20.88%-12.42%n/a
Price
-9.63%-9.32%-10.07%+3.56%
Total return
-9.63%-9.32%-10.07%+3.57%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
21.4×
P/OI (ttm)
21.8×
Fwd P/E
13.3×
P/S (ttm)
2.8×
P/B (mrq)
1.4×
P/FCF (ttm)
17.5×
EV/EBITDA (fy)
15.7×
EV/Sales (ttm)
3.4×
FCF yield (ttm)
5.72%
Buyback yield (realized, 1y)
4.36%
Shareholder yield (realized, 1y)
4.36%
Buyback yield (cash, ttm)
5.43%
Shareholder yield (cash, ttm)
5.43%

Vs own 10Y history

P/E
15th
P/OI
10th
P/S
2nd
P/B
2nd
P/FCF
2nd

Bar = where today’s multiple sits in COO’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-06#

Data provided bySource: Twelve Data
1D
-1.81%
5D
+4.72%
1M
+10.51%
3M
-14.95%
YTD
-23.91%
1Y
-9.62%
5Y
-41.20%
1D
-1.81%
5D
+4.72%
1M
+10.51%
3M
-14.95%
YTD
-23.91%
1Y
-9.62%
5Y
-41.18%

Fundamentals#

Revenue

5Y CAGR +11.0%10Y CAGR +8.6%YoY +0.6%
$4.2B TTM$1.1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +17.0%10Y CAGR +11.2%YoY +26.4%
$544.2M TTM$222M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +9.2%10Y CAGR +6.1%YoY +357.1%
$2.91 TTM$2.24 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +19.7%10Y CAGR +11.4%YoY +66.0%
$678M TTM$273M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $1B, capex −$355.3M

Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $341.7M, capex −$68.7M

Shares (diluted)

5Y +0.8%10Y +1.6%YoY −3.3%
195.8M TTM193.4M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +5.9%10Y CAGR +2.9%YoY +33.3%
— FY25— Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full COO financials →

The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. Through its CooperVision segment, the company develops, manufactures, and markets a broad range of contact lenses, including daily disposable, toric, multifocal, and specialty products designed to support different vision correction needs. Its CooperSurgical segment provides fertility, reproductive health, and women’s healthcare products and services, including medical devices, diagnostic tools, cryostorage solutions, and office-based surgical products. The Cooper Companies serves eye care professionals, fertility clinics, hospitals, and other healthcare providers across international markets. Headquartered in San Ramon, California, The Cooper Companies, Inc. plays an important role in specialized healthcare by combining consumer-facing vision products with clinical solutions for reproductive and women’s health.

San Ramon, CA·15,000 employees·Medical Instruments & Supplies·coopercos.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding COO#

30 of the 193 ETFs ChartRow carries live hold COO. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
VBRVanguard Small-Cap Value ETF0.3%
XLVHealth Care Select Sector SPDR Fund0.2%
RSPInvesco S&P 500 Equal Weight ETF0.2%
VHTVanguard Health Care ETF0.2%
VBVanguard Small-Cap ETF0.2%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
SPYVSPDR Portfolio S&P 500 Value ETF0.0%
TickerName1M1D
LLYEli Lilly and Company+16.98%-0.79%
JNJJohnson & Johnson+8.42%+1.43%
ABBVAbbVie Inc.+9.23%+1.07%
MRKMerck & Co. Inc.+3.37%-0.14%
UNHUnitedHealth Group Incorporated Common Stock (DE)+4.74%-0.40%
NVSNovartis AG+15.46%+0.38%
TMOThermo Fisher Scientific Inc.+5.81%+2.63%
AMGNAmgen Inc.+14.36%+0.03%